Tag: GeneDx

Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat

GeneDx Holdings Corp. (NASDAQ:WGS) has emerged as one of the top digital health stocks to invest in currently.